The risk of development of multiple primary malignant tumors involving the thyroid gland

Cover Page

Cite item

Full Text

Abstract

Aim. To determine the relative risk of developing other malignant tumors in patients with thyroid cancer and and the risk of developing thyroid cancer in patients with other malignancies. Methods. A retrospective analysis of 116 patients with multiple neoplasia including thyroid gland involvement was conducted for the period from 1973 to 2010. In order to estimate the relative risk of development of multiple neoplasias including thyroid gland lesions used was the following formula: relative risk = [a / (a + b)] / [c / (c + d)], where a is the number of patients with thyroid cancer with a second malignancy; b is the number of patients with thyroid cancer without a second malignancy; c is the number of patients in the population affected by the same malignant disease, as patients in group a; d is the number of people in the population without any cancer-related pathology. Results. In patients with carcinomas of the thyroid gland the relative risk is higher than in the general population for developing metachronous lymphoma (41.8 for men, 31.7 for women), renal cell carcinoma (55.6 for men, 18.5 for women), prostate cancer (35.7), lung and bronchus cancer (18.8 for women), melanoma (17.1 for women), colon cancer (16.7 for women), cervical cancer (15.8), uterine cancer (11.8), breast cancer (11.5 for women), skin cancer (9.5 in women) and the simultaneous development of renal cell carcinoma (33.8 for men and 46.3 for women), prostate cancer (24.4), melanoma (20.6 for women), cancer of the esophagus (19.4 for men, 17.8 for women), colon cancer (19.0 for men), lymphomas (12.8 for men), cervical cancer (11.3), breast cancer (11.0 for women), skin cancer (8.5 for women). The relative risk of developing metachronous cancer of the thyroid gland is higher than that in the population in patients with melanoma (108.0 in men, 50.4 for women), with malignant neoplasms of the lymphoid tissue (40.2 for men, 40.8 for women), uterine cancer (11.8), skin cancer (8.7 in women), breast cancer (8.0 for women). Conclusion. During preventive medical examinations of patients with thyroid cancer the relative risk of developing subsequent cancers must be taken into account for early diagnosis of multiple neoplasias.

About the authors

Z A Afanas’eva

Republican Clinical Oncological Dispensary, Kazan, Russia; Kazan State Medical Academy, Kazan, Russia

S F Bakunin

Kazan State Medical Academy, Kazan, Russia

Email: Sernaf-74@yandex.ru

References

  1. Гланц С.А. Медико-биологическая статистика (пер. с англ.). - М.: Практика, 1999. - 459 с.
  2. Зайцев В.М., Лифляндский В.Г., Маринкин В.И. Прикладная медицинская статистика. - СПб: Фолиант, 2006. - 432 с.
  3. Хасанов Р.Ш., Латыпова Р.Ф. Риск развития полинеоплазий у больных злокачественными новообразованиями // Нижегород. мед. ж. - 2005. - №1. - С. 146-153.
  4. Чиссов В.И. Состояние онкологической помощи населению России в 2009 году / Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой. - М.: МНИОИ им. П.А. Герцена Росмедтехнологий, 2010. - 195 с.
  5. Юрин А.Г. Критерии диагностики и правила регистрации злокачественных и доброкачественных первично-множественных опухолей // Вопр. онкол. - 2003. - Т. 49, №3. - С. 376-382.
  6. Ahmed F., Goodman M.T., Kosary C. et al. Excess risk of subsequent primary cancers among colorectal carcinoma survivors, 1975-2001 // Cancer. - 2006. - Vol. 107, N 5. - Р. 1162-1171.
  7. Andersson M., Jensen M.B., Engholm G. et al. Risk of second primary cancer among patients with early operable breast cancer registered or randomized in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmers during 1977-2001 // Acta Oncol. - 2008. - Vol. 47, N 4. - Р. 755-764.
  8. Barocas D.A., Rabbani F., Scherr D.S., Vaughan E.D.Jr. A population-based study of renal cell carcinoma and prostate cancer in the same patients // BJU International. - 2006. - Vol. 97, N 1. - Р. 33-36.
  9. Berthe E., Henry-Amar M., Michels J.-J. et al. Risk of second primary cancer following differentiated thyroid cancer // Eur. J. Nucl. Med. Mol. Imaging. - 2004. - Vol. 31. - Р. 685-691.
  10. Brennan P., Scélo G., Hemminki K. et al. Second primary cancers among 109 000 cases of non-Hodgkin’s lymphoma // Br. J. Cancer. - 2005. - Vol. 93, N 1. - Р. 159-166.
  11. Brown A.P., Chen J., Hitchcock Y.J. et al. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer // J. Clin. Endocrinol. Metab. - 2008. - Vol. 93, N 2. - Р. 504-515.
  12. Canchola A.J., Horn-Ross P.L., Purdie D.M. et al. Risk of second primary malignancies in women with papillary thyroid cancer // Am. J. Epidemiol. - 2006. - Vol. 163, N 6. - Р. 521-527.
  13. Chen A.Y., Levy L., Goepfert H. et al. The development of breast carcinoma in women with thyroid carcinoma // Cancer. - 2001. - Vol. 92, N 2. - Р. 225-231.
  14. Cluze C., Delafosse P., Seigneurin A. et al. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study // Eur. J. Cancer Prev. - 2009. - Vol. 18, N 5. - Р. 343-348.
  15. Lee K.D., Chen S.C., Chan C.H. et al. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan // Cancer Epid. Biomarkers Prev. - 2008. - Vol. 17, N 10. - Р. 2647-2655.
  16. Mellemkjaer L., Friis S., Olsen J.H. et al. Risk of second cancer among women with breast cancer // Int. J. Cancer. - 2006. - Vol. 118, N 9. - Р. 2285-2292.
  17. Ronckers C.M., McCarron P., Ron E. Thyroid cancer and multiple primary tumors in the SEER cancer registries // Int. J. Cancer. - 2005. - Vol. 117, N 2. - P. 281-288.
  18. Sandeep Th.C., Strachan M.W.J., Reynolds R.M. et al. Second primary cancers in thyroid cancer patients: a multinational record linkage study // J. Clin. Endocrinol. Metab. - 2006. - Vol. 91, N 5. - Р. 1819-1825.
  19. Spanogle J.P., Clarke C.A., Aroner S., Swetter S.M. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study // J. Am. Acad. Dermatol. - 2010. - Vol. 62, N 5. - Р. 757-767.
  20. Subramanian S., Goldstein D.P., Parlea L. et al. Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis // Thyroid. - 2007. - Vol. 17, N 12. - Р. 1277-1288.

© 2012 Afanas’eva Z.A., Bakunin S.F.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.




This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies